SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-20-000603
Filing Date
2020-11-09
Accepted
2020-11-09 12:42:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 nvus13g.htm SC 13G 59889
  Complete submission text file 0000935836-20-000603.txt   61516
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Subject) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88334 | Film No.: 201296852
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

IRS No.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G